Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, Canada (vol 75, pg 1980, 2022)

被引：0
|
作者：
不详
机构：
来源：
CLINICAL INFECTIOUS DISEASES | 2023年 / 76卷 / 04期
关键词：
D O I：
10.1093/cid/ciac584
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：778 / 779
页数：2
相关论文
共 6 条
  • [1] Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, Canada
    Skowronski, Danuta M.
    Febriani, Yossi
    Ouakki, Manale
    Setayeshgar, Solmaz
    El Adam, Shiraz
    Zou, Macy
    Talbot, Denis
    Prystajecky, Natalie
    Tyson, John R.
    Gilca, Rodica
    Brousseau, Nicholas
    Deceuninck, Genevieve
    Galanis, Eleni
    Fjell, Chris D.
    Sbihi, Hind
    Fortin, Elise
    Barkati, Sapha
    Sauvageau, Chantal
    Naus, Monika
    Patrick, David M.
    Henry, Bonnie
    Hoang, Linda M. N.
    De Wals, Philippe
    Garenc, Christophe
    Carignan, Alex
    Drolet, Melanie
    Jassem, Agatha N.
    Sadarangani, Manish
    Brisson, Marc
    Krajden, Mel
    De Serres, Gaston
    CLINICAL INFECTIOUS DISEASES, 2022, 75 (11) : 1980 - 1992
  • [2] Comparative Single-Dose mRNA and ChAdOx1 Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2, Including Variants of Concern: Test-Negative Design, British Columbia, Canada
    Skowronski, Danuta M.
    Setayeshgar, Solmaz
    Zou, Macy
    Prystajecky, Natalie
    Tyson, John R.
    Sbihi, Hind
    Fjell, Chris D.
    Galanis, Eleni
    Naus, Monika
    Patrick, David M.
    El Adam, Shiraz
    Ahmed, May A.
    Kim, Shinhye
    Henry, Bonnie
    Hoang, Linda M. N.
    Sadarangani, Manish
    Jassem, Agatha N.
    Krajden, Mel
    JOURNAL OF INFECTIOUS DISEASES, 2022, : 11 - 22
  • [3] Single-dose mRNA Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Including Alpha and Gamma Variants: A Test-negative Design in Adults 70 Years and Older in British Columbia, Canada (vol 74, pg 1158, 2022)
    不详
    CLINICAL INFECTIOUS DISEASES, 2023, 76 (07) : 1347 - 1347
  • [4] Single-Dose Messenger RNA Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 in Healthcare Workers Extending 16 Weeks Postvaccination: A Test-Negative Design From Quebec, Canada
    Carazo, Sara
    Talbot, Denis
    Boulianne, Nicole
    Brisson, Marc
    Gilca, Rodica
    Deceuninck, Genevieve
    Brousseau, Nicholas
    Drolet, Melanie
    Ouakki, Manale
    Sauvageau, Chantal
    Barkati, Sapha
    Fortin, Elise
    Carignan, Alex
    De Wals, Philippe
    Skowronski, Danuta M.
    De Serres, Gaston
    CLINICAL INFECTIOUS DISEASES, 2022, 75 (01) : E805 - E813
  • [5] Single-dose mRNA Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Including Alpha and Gamma Variants: A Test-negative Design in Adults 70 Years and Older in British Columbia, Canada
    Skowronski, Danuta M.
    Setayeshgar, Solmaz
    Zou, Macy
    Prystajecky, Natalie
    Tyson, John R.
    Galanis, Eleni
    Naus, Monika
    Patrick, David M.
    Sbihi, Hind
    El Adam, Shiraz
    Henry, Bonnie
    Hoang, Linda M. N.
    Sadarangani, Manish
    Jassem, Agatha N.
    Krajden, Mel
    CLINICAL INFECTIOUS DISEASES, 2022, 74 (07) : 1158 - 1165
  • [6] SARS-CoV-2 mRNA Vaccine Effectiveness in Health Care Workers by Dosing Interval and Time Since Vaccination: Test-Negative Design, British Columbia, Canada (vol 9, ofac178, 2022)
    Adam, S. E.
    Zou, M.
    Kim, S.
    OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (08):
1